B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2017

  • ID: 4311645
  • Clinical Trials
  • Region: Global
  • 1463 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • AstraZeneca Plc
  • Celgene Corp
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • MORE
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2017

Summary:

The clinical trial report, 'B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2017' provides an overview of B-Cell Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Non-Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope:
  • The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy:
  • Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • AstraZeneca Plc
  • Celgene Corp
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • MORE
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on B-Cell Non-Hodgkin Lymphoma
Apr 13, 2017: Altor BioScience and CMC Biologics Announce Agreement for Manufacture and Validation of Altor’s IL-15 Superagonist Molecule, ALT-803, for use in Phase 3 Clinical Trials
Apr 06, 2017: Kite Wins 'Clinical Trial Result of the Year' for its Pivotal CAR-T Trial of Axicabtagene Ciloleucel in Patients with Aggressive Non-Hodgkin Lymphoma at the 2017 Clinical and Research Excellence Awards
Apr 02, 2017: Kite Presents Ongoing Response Rate in Plenary Session from its Pivotal CAR-T Trial of Axicabtagene Ciloleucel in Patients with Aggressive Non-Hodgkin Lymphoma at the 2017 American Association of Cancer Research Annual Meeting
Feb 28, 2017: Kite Announces Positive Topline Primary Results of Axicabtagene Ciloleucel from First Pivotal CAR-T Trial in Patients with Aggressive Non-Hodgkin Lymphoma
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About the Publisher
Contact Us
Disclaimer
Source

List of Tables:
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017
Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017
Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
B-Cell Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017

List of Figures:
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017
Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017
Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
B-Cell Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017
Methodology
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • F. Hoffmann-La Roche Ltd
  • Celgene Corp
  • Johnson & Johnson
  • AbbVie Inc
  • Takeda Pharmaceutical Company Ltd
  • Novartis AG
  • Amgen Inc
  • GlaxoSmithKline Plc
  • Pfizer Inc
  • AstraZeneca Plc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll